Literature DB >> 2110946

Mean cell volume of human blood leucocytes and resident and activated murine macrophages.

P H Nibbering1, T P Zomerdijk, A J Corsèl-Van Tilburg, R Van Furth.   

Abstract

The mean cell volume (MCV) of human blood leucocytes and resident and activated murine macrophages was measured with a Coulter counter connected to a 256 channelyzer. The values found for human blood monocytes, granulocytes, and lymphocytes were 421 +/- 24 femtolitre (fl), 334 +/- 32 fl, and 204 +/- 19 fl, respectively. Resident murine peritoneal macrophages were significantly smaller than rIFN-gamma-activated and BCG/PPD-activated peritoneal macrophages and resident alveolar macrophages.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2110946     DOI： 10.1016/0022-1759(90)90432-u

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


  27 in total

1.  Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.

Authors:  S Krasniqi; P Matzneller; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

2.  Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis.

Authors:  Paul Beringer; Kitty My Tu Huynh; Jane Kriengkauykiat; Luke Bi; Nils Hoem; Stan Louie; Emily Han; Thao Nguyen; Donald Hsu; Purush A Rao; Bertrand Shapiro; Mark Gill
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1,500 milligrams, given over a 3- or 5-day period in healthy subjects.

Authors:  G W Amsden; A N Nafziger; G Foulds
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages.

Authors:  N Mor; B Simon; L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

5.  Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy.

Authors:  P Matzneller; S Krasniqi; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

6.  Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen.

Authors:  Ping Liu; Hameed Allaudeen; Richa Chandra; Kem Phillips; Arvid Jungnik; Jeanne D Breen; Amarnath Sharma
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

7.  Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells.

Authors:  Tatsuro Iso; Takafumi Suzuki; Liam Baird; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

8.  Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

Authors:  Dean Y Maeda; Mark T Quinn; Igor A Schepetkin; Liliya N Kirpotina; John A Zebala
Journal:  J Pharmacol Exp Ther       Date:  2009-09-24       Impact factor: 4.030

9.  Inhibition of HIV Expression and Integration in Macrophages by Methylglyoxal-Bis-Guanylhydrazone.

Authors:  Xia Jin; Michael S McGrath; Hua Xu
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

10.  Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP.

Authors:  M J A van der Plas; M Baldry; J T van Dissel; G N Jukema; P H Nibbering
Journal:  Diabetologia       Date:  2009-07-03       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.